Literature DB >> 31469100

Glycolytic reprogramming in cancer cells: PKM2 dimer predominance induced by pulsatile PFK-1 activity.

Xiangguang Shi1, Lingchong You, Ruo-Yu Luo.   

Abstract

The glycolytic enzyme pyruvate kinase M2 (PKM2) exists in both catalytically inactive dimeric and active tetrameric forms. In cancer cells, PKM2 dimer predominance contributes to tumor growth by triggering glycolytic reprogramming. However, the mechanism that promotes PKM2 dimer predominance over tetramer in cancer cells remains elusive. Here, we show that pulsatile phosphofructokinase (PFK-1) activity results in PKM2 dimer predominance. Mathematical simulations predict that pulsatile PFK-1 activity prevents the formation of PKM2 tetramer even under high levels of fructose-1,6-bisphosphate (FBP), a PKM2 tetramer-promoting metabolite produced by PFK-1. We experimentally confirm these predictions at the single-molecule level by providing evidence for pulsatile PFK-1 activity-induced synchronized dissociation of PKM2 tetramers and the subsequent accumulation of PKM2 dimers under high levels of FBP in HeLa cells. Moreover, we show that pulsatile PFK-1 activity-induced PKM2 dimer predominance also controls cell proliferation. Thus, our study reveals the significance of pulsatile PFK-1 activity in cancer cell metabolism.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31469100     DOI: 10.1088/1478-3975/ab3f5a

Source DB:  PubMed          Journal:  Phys Biol        ISSN: 1478-3967            Impact factor:   2.583


  3 in total

Review 1.  Tools used to assay genomic instability in cancers and cancer meiomitosis.

Authors:  Jennifer Gantchev; Brandon Ramchatesingh; Melissa Berman-Rosa; Daniel Sikorski; Keerthenan Raveendra; Laetitia Amar; Hong Hao Xu; Amelia Martínez Villarreal; Daniel Josue Guerra Ordaz; Ivan V Litvinov
Journal:  J Cell Commun Signal       Date:  2021-11-29       Impact factor: 5.908

2.  lncRNA NEAT1 promotes the proliferation and metastasis of hepatocellular carcinoma by regulating the FOXP3/PKM2 axis.

Authors:  Junping Pan; Yingzhe Hu; Chenlu Yuan; Yafu Wu; Xinhua Zhu
Journal:  Front Oncol       Date:  2022-09-15       Impact factor: 5.738

3.  Mir-488 alleviates chemoresistance and glycolysis of colorectal cancer by targeting PFKFB3.

Authors:  Xiaojing Deng; Dapeng Li; Xiquan Ke; Qizhi Wang; Shanjun Yan; Yongju Xue; Qiangwu Wang; Hailun Zheng
Journal:  J Clin Lab Anal       Date:  2020-09-29       Impact factor: 2.352

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.